FR2960781B1 - Preparation d'un vaccin oral sec stabilise, compose d'un virus vivant attenue - Google Patents

Preparation d'un vaccin oral sec stabilise, compose d'un virus vivant attenue

Info

Publication number
FR2960781B1
FR2960781B1 FR1054443A FR1054443A FR2960781B1 FR 2960781 B1 FR2960781 B1 FR 2960781B1 FR 1054443 A FR1054443 A FR 1054443A FR 1054443 A FR1054443 A FR 1054443A FR 2960781 B1 FR2960781 B1 FR 2960781B1
Authority
FR
France
Prior art keywords
preparation
oral vaccine
live virus
attenuated live
dry oral
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR1054443A
Other languages
English (en)
Other versions
FR2960781A1 (fr
Inventor
Pierre Chouvenc
Alain Francon
Catherine Noel
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanofi Pasteur Inc
Original Assignee
Sanofi Pasteur Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Pasteur Inc filed Critical Sanofi Pasteur Inc
Priority to FR1054443A priority Critical patent/FR2960781B1/fr
Priority to PCT/EP2011/002760 priority patent/WO2011154119A1/fr
Publication of FR2960781A1 publication Critical patent/FR2960781A1/fr
Application granted granted Critical
Publication of FR2960781B1 publication Critical patent/FR2960781B1/fr
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/125—Picornaviridae, e.g. calicivirus
    • A61K39/13—Poliovirus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5254—Virus avirulent or attenuated
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/32011—Picornaviridae
    • C12N2770/32611—Poliovirus
    • C12N2770/32634—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
FR1054443A 2010-06-07 2010-06-07 Preparation d'un vaccin oral sec stabilise, compose d'un virus vivant attenue Expired - Fee Related FR2960781B1 (fr)

Priority Applications (2)

Application Number Priority Date Filing Date Title
FR1054443A FR2960781B1 (fr) 2010-06-07 2010-06-07 Preparation d'un vaccin oral sec stabilise, compose d'un virus vivant attenue
PCT/EP2011/002760 WO2011154119A1 (fr) 2010-06-07 2011-06-06 Fabrication d'un vaccin sec stabilisé à administration par voie orage à partir d'un virus vivant atténué

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR1054443A FR2960781B1 (fr) 2010-06-07 2010-06-07 Preparation d'un vaccin oral sec stabilise, compose d'un virus vivant attenue

Publications (2)

Publication Number Publication Date
FR2960781A1 FR2960781A1 (fr) 2011-12-09
FR2960781B1 true FR2960781B1 (fr) 2013-11-22

Family

ID=44312310

Family Applications (1)

Application Number Title Priority Date Filing Date
FR1054443A Expired - Fee Related FR2960781B1 (fr) 2010-06-07 2010-06-07 Preparation d'un vaccin oral sec stabilise, compose d'un virus vivant attenue

Country Status (2)

Country Link
FR (1) FR2960781B1 (fr)
WO (1) WO2011154119A1 (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3581202A1 (fr) * 2018-06-14 2019-12-18 University College Cork-National University of Ireland, Cork Composition et procédé de stabilisation de vaccins dans un format de dosage solide
CN110585439B (zh) * 2019-09-30 2023-06-09 长春生物制品研究所有限责任公司 一种改良型的冻干甲型肝炎减毒活疫苗稳定剂、疫苗半成品、疫苗成品及其制备方法
CN116874555B (zh) * 2023-09-08 2023-11-28 成都华任康生物科技有限公司 一种置换液及其试剂盒和相关应用

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8801338D0 (en) 1988-01-21 1988-02-17 Quadrant Bioresources Ltd Preservation of viruses
DD299213A7 (de) 1988-05-04 1992-04-09 Saechsische Landesgewerbefoerderungsgesellschaft M.B.H.,De Verfahren zur stabilisierung eines lebendvirusimpfstoffes gegen temperatureinwirkung
FR2702660B1 (fr) 1993-03-17 1995-05-24 Karl Simpson Compositions thérapeutiques stabilisées et leur procédé de préparation.
FR2742756B1 (fr) * 1995-12-22 1998-04-03 Pasteur Merieux Serums Vacc Stabilisants pour vaccins vivants, vaccins les contenant et procedes pour leur preparation
ATE421337T1 (de) * 1998-11-16 2009-02-15 Introgen Therapeutics Inc Adenovirus-formulierungen zur gentherapie
CN100379451C (zh) * 1999-08-17 2008-04-09 史密丝克莱恩比彻姆生物有限公司 疫苗
GB0020089D0 (en) * 2000-08-15 2000-10-04 Smithkline Beecham Biolog Vaccine Composition
US7927858B2 (en) 2002-11-01 2011-04-19 Glaxosmithkline Biologicals, S.A. Drying process
CN104984352A (zh) * 2005-11-21 2015-10-21 圣诺菲·帕斯图尔有限公司 重组病毒的稳定制剂
EP2143440A1 (fr) 2008-07-09 2010-01-13 Sanofi Pasteur Agent stabilisant et composition vaccinale comprenant un ou plusieurs flavivirus vivants atténués
US8557253B2 (en) * 2009-10-07 2013-10-15 Sanofi Pasteur Sa Stabilizing excipient for inactivated whole virus vaccine

Also Published As

Publication number Publication date
WO2011154119A1 (fr) 2011-12-15
FR2960781A1 (fr) 2011-12-09

Similar Documents

Publication Publication Date Title
MY150613A (en) Stabilizer and vaccine composition comprising one or more live attenuated flaviviruses
GEP201706734B (en) FORMULATION FOR ANTI-α4β7 ANTIBODY
IN2012DE00337A (fr)
EA201100896A1 (ru) Композиция, предназначенная для всасывания никотина из ротовой полости с целью прекратить курение
BR112015021814A2 (pt) aglomerados respiráveis de partículas carreadoras porosas e fármaco micronizado
EA201201321A1 (ru) Соединения (липопептиды на основе цистеина) и композиции в качестве агонистов tlr2, применяемые для лечения инфекционных, воспалительных, респираторных и других заболеваний
CO2017012766A2 (es) Unidad de dosificación orodispersable que contiene un componente estetrol
FI3258919T4 (fi) Nasaalinen jauheformulaatio hypoglykemian hoitoon
EA201390409A1 (ru) Составы с низкой дозой панкрелипазы и кишечно-растворимым покрытием
CL2011003003A1 (es) Composicion tensioactiva reconstituida que comprende un polipeptido análogo a la proteína surfactante c nativa, un polipeptido análogo a la proteína surfactante b nativa, un fosfolipido monoinsaturado y un fosfolipido saturado, útil para el tratamiento del síndrome de dificultad respiratoria.
RU2014142551A (ru) Бездымная табачная композиция, содержащая нетабачные волокна, и способ ее приготовления
RU2014122945A (ru) Композиции для лечения сухости глаза
EA201170289A1 (ru) Фармацевтические композиции и способы их получения при низкой концентрации примесей
EA201291306A1 (ru) Состав сухого порошка, содержащий антимускариновое средство
GB201216469D0 (en) Stabilisation of viral particles
JP2013524782A5 (fr)
EA201200850A1 (ru) Фармацевтическая композиция, содержащая олигопептиды
EA201390812A1 (ru) Лиофилизированные вирусные составы
EA201490395A1 (ru) Способ получения фармацевтических композиций, содержащих финголимод
EA201390810A1 (ru) Жидкие вирусные составы
EA201991023A1 (ru) Фармацевтическая композиция для парентерального введения, содержащая карглумовую кислоту
EA202092926A2 (ru) Лиофилизированные составы, содержащие фактор ix
FR2960781B1 (fr) Preparation d'un vaccin oral sec stabilise, compose d'un virus vivant attenue
EA201490363A1 (ru) Новые составы на основе (триметоксифениламино)пиримидинилов
JP2016507535A5 (fr)

Legal Events

Date Code Title Description
PLFP Fee payment

Year of fee payment: 7

PLFP Fee payment

Year of fee payment: 8

PLFP Fee payment

Year of fee payment: 9

ST Notification of lapse

Effective date: 20200205